Zobrazeno 1 - 10
of 26
pro vyhledávání: '"G E Rovati"'
Autor:
Christian Pinna, Paolo Ciana, Electra Brunialti, G. E. Rovati, Giuseppe Battaglia, Massimo Locati, Chiara Sfogliarini, Elisabetta Vegeto, Giovanna Pepe, Adriana Maggi, Loris Rizzello, Federica Mornata
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Biomedicine & Pharmacotherapy, Vol 144, Iss, Pp 112274-(2021)
Biomedicine & Pharmacotherapy
Universidad de Barcelona
Biomedicine & Pharmacotherapy, Vol 144, Iss, Pp 112274-(2021)
Biomedicine & Pharmacotherapy
Sex differences in immune-mediated diseases are linked to the activity of estrogens on innate immunity cells, including macrophages. Tamoxifen (TAM) is a selective estrogen receptor modulator (SERM) used in estrogen receptor-alpha (ERα)-dependent br
Autor:
Fabio Stellari, Patrizia Risé, Thierry Durand, Annalisa Trenti, Angelo Sala, Carola Buccellati, Chiara Bolego, Dayaker Gandrath, G. E. Rovati, Laurence Balas
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (21), pp.9961-9975. ⟨10.1021/acs.jmedchem.9b01463⟩
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (21), pp.9961-9975. ⟨10.1021/acs.jmedchem.9b01463⟩
International audience; Protectin D1 [neuroprotectin D1 (NPD1), PD1] has been proposed to play a key role in the resolution of inflammation. Aside from its ω-monohydroxylated metabolite, little has been reported on its metabolic fate. Upon NPD1 incu
Autor:
Emanuele Borroni, Ivan Brivio, Antonio Di Gennaro, Valérie Capra, Chiara Carnini, Marco Fiumicelli, Silvia Carnevali, Paolo Mangano, Carola Buccellati, Maria Rosa Accomazzo, Angelo Sala, G. E. Rovati
Publikováno v:
Prostaglandins & Other Lipid Mediators. 120:115-125
We evaluated the autocrine activities of cysteinyl leukotrienes (cysteinyl-LTs) in HUVEC and studied the signaling and the pharmacological profile of the CysLT2 receptor (CysLT2R) expressed by ECs, finally assessing the role of the CysLT2R in permeab
Autor:
G. E. Rovati, Valérie Capra
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 12(5)
Autor:
M. Hoxha, V. Capra, C. Buccellati, A. Sala, C. Cena, R. Fruttero, M. Bertinaria, G. E. Rovati
Today COXIBs are used in the treatment of arthritis and many other painful conditions in selected patients with high gastrointestinal risk and low cardiovascular (CV) risk. Previously, we have identified an unexpected mechanism of action of a traditi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9ccfd827818ed082cc7126f88005fe
http://hdl.handle.net/2318/1523595
http://hdl.handle.net/2318/1523595
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 14:3-19
This review describes the aspects of leukotriene (LT) pharmacology and biology that are relevant to their important role in asthma. The biosynthesis and metabolism, including transcellular metabolism, of LTB4 and the cysteinyl-LTs (i.e. LTC4, LTD4 an
Autor:
Nicosia S, G. E. Rovati
Publikováno v:
Trends in Pharmacological Sciences. 15:140-144
It is very common in practice to find that some concentration-response curves are ‘bell shaped', and this phenomenon also applies to partial agonist curves. On the basis of these considerations, a mathematical model has been developed for the inter
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 38(5)
Montelukast is a potent cysteinyl leukotriene-1 receptor antagonist possessing some anti-inflammatory effects although the molecular mechanism of these anti-inflammatory effects is unknown. In this study, we aimed to investigate the effect of montelu
Autor:
E, Selg, C, Buccellati, M, Andersson, G E, Rovati, M, Ezinga, A, Sala, A-K, Larsson, M, Ambrosio, E, Ambrosio, L, Låstbom, V, Capra, B, Dahlén, A, Ryrfeldt, G C, Folco, S-E, Dahlén
Publikováno v:
British journal of pharmacology. 152(8)
Non-steroidal anti-inflammatory drugs (NSAIDs) are analgesic and anti-inflammatory by virtue of inhibition of the cyclooxygenase (COX) reaction that initiates biosynthesis of prostaglandins. Findings in a pulmonary pharmacology project gave rise to t
Publikováno v:
Molecular pharmacology. 57(6)
We report the identification of a novel pharmacological profile for the leukotriene (LT)C(4) binding site we previously identified in human lung parenchyma (HLP). We used a series of classic cysteinyl-LT (CysLT)(1) receptor antagonists belonging to d